Naltrexone is a class of drug known as an opiate antagonist. Its normal use is in treating
addiction to opiate drugs such as heroin or morphine. The dose used for this purpose is
usually between 50 and 300mg daily.
Low-dose Naltrexone (LDN) has been used in the treatment of autoimmune diseases in
the USA since 1985, but is relatively new in the United Kingdom and Europe. Despite
the fact that the drug is used at a very low dose, the occurrence of significant
introductory or long term side effects cannot be excluded.
This method was devised and subsequently developed by the late Dr Bernard Bihari, a
Neurophysician from New York, USA who passed away on May 16th 2010. Dr Bihari
was qualified in Internal Medicine, Psychiatry and Neurology, and we hope to honour
him by continuing with his pioneering work.
Naltrexone is a class of drug known as an opiate antagonist. Its normal use is in treating
addiction to opiate drugs such as heroin or morphine. The dose used for this purpose is
usually between 50 and 300mg daily.
Low-dose Naltrexone (LDN) has been used in the treatment of autoimmune diseases in
the USA since 1985, but is relatively new in the United Kingdom and Europe. Despite
the fact that the drug is used at a very low dose, the occurrence of significant
introductory or long term side effects cannot be excluded.
This method was devised and subsequently developed by the late Dr Bernard Bihari, a
Neurophysician from New York, USA who passed away on May 16th 2010. Dr Bihari
was qualified in Internal Medicine, Psychiatry and Neurology, and we hope to honour
him by continuing with his pioneering work.
การแปล กรุณารอสักครู่..